Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — One Year On, Advocates Say Biden Hasn’t Acted on Marijuana Promises

President Joseph Biden won office on a mostly progressive platform; he wanted to completely electrify the country’s transport sector and pass modest cannabis reform. Although most drug reform activists would much rather prefer more comprehensive reform, Biden was able to beat former President Donald Trump and take office. Since then, Biden has invested a significant amount of time working on an infrastructure bill that would, among other things, build a public network of charging stations.

However, a year after the Democrats clinched the Senate, House and White House, cannabis reform advocates say Biden still hasn’t acted on any of his modest cannabis promises. In fact, his administration’s actions on cannabis policy have been, by and large, restrictive and even hostile. Cannabis is still criminalized under federal law; thousands of individuals are still imprisoned for nonviolent cannabis offenses and the Controlled Substances Act still classifies cannabis as a Schedule I controlled substance with no medical use.

This is despite the fact that more than 30 states have legalized cannabis for medical use and around 3.6 million patients across the country are actively benefiting from medical cannabis products made by leading companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF).

One positive thing the Biden administration has done for cannabis policy has been to let states implement their own cannabis policies without federal intervention. However, the federal government’s hands-off policy when it comes to the state-legal marijuana industry has also led to a lack of clarity that causes problems for both consumers and industry stakeholders. Furthermore, the U.S. Department of Housing and Urban Development (HUD) continues to deny people who use state-legal cannabis access to federally assisted housing.

Given the fact that Biden made marijuana policy a part of his presidential campaign platform, many advocates are disappointed that he still hasn’t made any moves. The fact that the White House punished staff who admitted to past marijuana use and included a budget proposal to ban Washington, DC, from legalizing marijuana sales doesn’t help. Morgan Fox, NORML’s new political director says, it is “extremely disappointing that Biden has failed to live up to his campaign promises and has even made moves designed to set the burgeoning industry back.”

The administration’s inaction on even modest cannabis reforms for the past 12 months is “inexcusable,” says Fox, and it is a betrayal of the voters who put Biden in the Oval Office. This disregard for cannabis reform will undoubtedly have a negative impact on the Democratic Party come the 2024 elections, he predicts.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — What the Recreational Marijuana Industry Can Learn from the Tobacco Industry

The recreational marijuana space has grown significantly these past few years. Given its growth rate, however, it’s easy to wonder if there are things that may hinder it from progressing further. To find possible obstructions for this burgeoning industry, one only needs to look at the tobacco industry.

Despite the fact that marijuana hasn’t been legalized federally, there are plenty of similarities between the businesses and companies in the tobacco industry and those involved in the recreational marijuana industry. For the legal marijuana industry to continue growing, it is important that the sector doesn’t repeat the same mistakes the tobacco industry made in the 20th century.

Below, we look at some of the lessons the marijuana industry can learn from big tobacco.

Be adaptable

The banning of cigarette vending machines significantly impacted cigarette sales, with sales in the tobacco industry, which were already low, sinking even lower. Big tobacco was already recording declines in sales even before 2020 because of its frigidity when it comes to adaptability.

To prevent this from happening in the cannabis industry, companies need to be more adaptable when it comes to sales regulations. At the moment, marijuana vending machines are growing in popularity, but who’s to say they won’t be affected if stricter regulations are put in place? This is why the flourishing industry needs to be more prepared for any changes that may be made and find ways to adapt in the quickest way.

Be honest

The tobacco industry made the mistake of not being honest about the risks linked to the use of tobacco in its early days. Advertisements with doctors endorsing the use of cigarettes were common in the 1930s, which continued for decades, with tobacco executives claiming that cigarettes weren’t addictive even in the late ‘90s.

For the marijuana industry to remain in the good graces of regulators and maintain trust with consumers, it needs to be upfront and honest about the risks linked to the use of certain marijuana products.

Be mindful of the marketing practices used

A product such as marijuana can prompt business owners to behave in ways that disproportionately affect young people, as was seen in how the tobacco industry impacted people of color and younger individuals. This is why keeping marijuana products out of children’s hands is an important responsibility for recreational marijuana companies.

Overall, the industry needs to be prepared for changes and adapt more easily than the tobacco industry in order to achieve and maintain a high sales volume consistently as many reputable companies aspire to.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is not realistic: it takes time, evidence and a lot of positive results to overcome industry inertia. We have long been hopeful that, before the end of 2022, we will have built sufficient data to effect meaningful industry and/or regulatory progress and sustainable increases in valuation… Before 2022 ends, we expect to have at least one major regulatory advancement such as an IND program approval, or one major new industry partner. We believe either of those will support what could be significantly higher valuations. If we are able to achieve more than one of these advancements…so much the better.”

To view the full press release, visit https://cnw.fm/G1Th6

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp. “As an award-winning expert in operations management, the appointment of Joël Reyes comes at the perfect time as Flora Growth’s aggressive global brand expansion and M&A strategy continue to be implemented.”

To view the full press release, visit https://cnw.fm/QWH9j

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Study Finds Banking Activity Grows Once a State Legalizes Cannabis

Cannabis businesses often find it difficult to get banks willing to take them on as clients because of the risks posed by the federal prohibition of marijuana. Now new research has found that once a state legalizes cannabis, banking activity increases. While the study doesn’t directly link increased banking activity and state-level cannabis reform, it does imply the existence of the relationship.

The study was conducted by researchers from Drexel University, the University of Arizona, Scripps College and San Diego State University.

For their study, the researchers looked into banking trends in states that have legalized marijuana, examining the Federal Deposit Insurance Corporation’s bank regulatory filings in the 2011–2016 period. The researchers conducted an analysis of data from more than 150,000 bank-quarter observations sourced from almost 7,000 different banks located in 46 states.

They discovered evidence showing significant increases in banking activity, i.e., deposits and subsequent loans, in states that had legalized marijuana in comparison to those that had not. For example in their report, they highlighted that bank lending grew by between 6.5–8.6% and deposits grew by an average range of 3.1–4.3% after states legalized marijuana.

This is despite the fact that credit unions and banks may be penalized by federal regulators for working with businesses dealing with marijuana as the drug is still classified as a controlled substance under the Controlled Substances Act.

As of June 2021, 705 financial institutions had filed reports stating that they were serving marijuana clients. While this is a slight increase from the 687 institutions who filed requisite reports in the previous quarter, it’s still below the 747 recorded in late 2019.

In their paper, the researchers also discussed possibilities of why the risk from regulatory uncertainty didn’t reduce the willingness of banks to make loans or accept deposits. They reasoned that the increase suggested that banks were either optimistic that regulations would probably adapt to the needs of states that had legalized marijuana or unconcerned about the possible risk linked to accepting marijuana related deposits.

The researchers note that evidence for instances where these financial institutions lose their federally insured status or are criminally prosecuted is lacking, which makes sense why banks don’t necessarily respond to the legislative uncertainty for federal marijuana prohibition.

The group observed that as more state regulators issued statements supporting credit unions and banks that served the marijuana industry, financial institutions would become more optimistic about the chance that regulations will be adjusted in their favor with time. This would ultimately mean that cannabis sector actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) would have more options to choose from when they need different banking services.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Thailand Reveals Plan to Legalize Recreational Cannabis

Cannabis reform is sweeping across the globe and undoing decades of prohibition. While the West has been the leader in cannabis legislation, the movement hasn’t been constrained to America, Canada and European nations. In Asia, Thailand entered the history books as the first southeast Asian country to legalize cannabis for medical use and in cosmetics and food. Three years after Thailand made history, the country is planning to legalize marijuana and do away with jail terms for people charged with marijuana possession.

Thailand’s Food and Drug Administration is poised to propose the removal of the controversial plant from the country’s list of restricted drugs to the Office of the Narcotics Control Board. Once the board clears the proposal, it will head to the health minister for approval. If the proposal is successful, Thailand will be one step closer to legalizing adult-use cannabis, another first in the region. There will be no more jail terms for cannabis offenses, and people won’t have to worry about long stints in jail for cannabis possession.

Currently, marijuana possession is punishable by up to 15 years in jail in Thailand. According to Thailand FDA’s deputy secretary-general Withid Sariddeechaikool, the move to decriminalize cannabis in the country will benefit its citizens. Thailand could take advantage of not just certain parts of the plant such as the flower but the entire plant, he says. If the government is able to decriminalize cannabis, the plant’s flower buds and seeds could provide a viable economic opportunity that is compliant with the law. And given how lucrative America’s cannabis market has been, Thailand could potentially generate a significant amount of money from cannabis sales.

However, the country has taken a slower legalization route, starting with rules to loosen marijuana possession and use rules. Interestingly, individual possession of marijuana is still prohibited by the law, but businesses have more access to the plant. Krungsri Research analyst Chaiwat Sowcharoensuk says that companies which produce soaps, cosmetics and beauty products stand to gain the most from reduced cannabis prohibition. As lawmakers change laws to allow the sale and use of every part of the cannabis plant, he says, it is likely that recreational use will be controlled.

Regardless, Thailand has still made noteworthy strides, especially considering how harshly countries in the southeast Asia region have treated drug offenses in the past. Historically, countries such as the Philippines, Indonesia, Singapore, Malaysia and Vietnam have issued extremely punitive punishments, including the death penalty, for drug use.

The steps being taken by Thailand could set a precedent that other southeast Asian countries may emulate, which could open up huge markets that internationally focused firms such as Flora Growth Corp. (NASDAQ: FLGC) could serve.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strategically Pursuing Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is riding the popularity of its trademarked Platinum Vape to remarkable revenue growth, recording a 93% year-over-year increase in its recently released third-quarter financial report. “The financial results note that the majority of the company’s revenue comes from sales of cannabis finished products through third-party wholesaling to retailers, delivering quarterly revenue of $11.8 million and EBITDA of $5.9 million that reverses an EBITDA loss of $5.8 million in Q3 2020 for a gain of $11.9 million,” reads a recent article, which also includes comments by RWB chairman and CEO Brad Rogers as well as CFO Chris Ecken. On his part, Rogers said, “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan and California to become more vertically integrated where it will be most profitable… This will help drive increased revenue and margins for the company.” Ecken further added, “RWB is being very strategic in pursuing vertical integration only when there is value to be added. We aim to be asset light and brand rich.”

To view the full article, visit https://cnw.fm/OfGf8

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — A Look at the Link Between Marijuana and Inflammation

Inflammation personifies the saying “too much of a good thing is bad.” Despite being one of the body’s first responders in case of infection or physical injury, inflammation also presents a significant risk to health. Acute inflammation is the body’s initial response to either infection or injury, and it is a crucial component of the body’s defense system. Chronic inflammation, on the other hand, happens when the body keeps sending inflammatory cells when there’s no present danger.

A wide variety of medical inflammations including Alzheimer’s disease, asthma, heart disease and cancer can be traced to chronic inflammation. This kind of inflammation usually results in symptoms such as pain in the abdomen, chest and joints, as well as fever, fatigue, headaches, swelling, mood disorders, and skin rashes. Current pharmaceutical medications for chronic inflammation can be quite effective at mitigating the condition, but they tend to cause adverse side effects after long-term use. Unsurprisingly, cannabis has emerged as a viable alternative due to its potent anti-inflammatory properties.

Studies have found that cannabis can function as an effective anti-inflammation agent because of how cannabinoids such as THC and CBD interact with the body. When you ingest cannabis, the cannabinoids interact with the endocannabinoid system (“ECS”), a part of the peripheral nervous system that regulates various functions, including immune response, sleep, appetite and mood. The ECS is filled with CB1 and CB2 receptors that normally respond to naturally produced endocannabinoids similar to the ones in cannabis. By interacting with this system, cannabis helps to inhibit chronic inflammation and mitigates its symptoms.

For instance, a study involving patients afflicted with Crohn’s disease found that 10 out of 11 participants enjoyed some relief from the condition after consuming marijuana. And since cannabis generally has no adverse side effects, the patients were able to avoid the adverse effects that usually result from long-term pharmaceutical drug use.

The controversial plant appears to be effective at easing the symptoms of cancer and cancer treatment, including nausea, insomnia and lack of appetite. HIV patients can also benefit from cannabis treatment as it can alleviate a variety of symptoms and significantly improve the quality of their lives.

Even with the limited research available, cannabis presents an effective alternative to pharmaceuticals for treating inflammatory conditions. Its side effects are inconveniences at best, and the substance can deliver a significant reduction in chronic inflammation. Consult your doctor if you would like to use cannabis to treat an inflammatory condition, and the doctor could also advise you about the best type of product for your needs, including the possibility of using a cannabis beverage made by one of the leading brands such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Three Trends That Could Define the Cannabis Sector for Decades to Come

Recent years have seen acceleration in the movement to reform marijuana policies not only in the United States but around the world. With that momentum, a number of trends that appear to have staying power have taken shape. We look at some of those trends and what impact they could have on the industry going forward.

Cannabis and health/wellness

Gone are the days when marijuana was viewed as a substance intended for people who simply want to get high. Today, this plant has developed strong links with the health and wellness industries, a link that is likely to be a defining factor in the way the marijuana industry evolves.

For example, many states that legalize marijuana start out by legalizing its medicinal use before recreational use eventually comes into the picture. The legalization of medical marijuana sends a strong message that potential therapeutic benefits exist for users of this substance, and that inevitably spills over to those who wish to support their wellness, even if they aren’t battling any specific ailment.

Cannatourism

The decades of prohibition of marijuana and the recent wave of legalizations has piqued the interest of people around the world. Even in the U.S., cannabis tourism is thriving, with states such as Oregon, Colorado and California earning millions from out-of-state visitors who enter the state to sample available products, to visit cannabis grow facilities and to learn about this controversial plant. The Netherlands has also been a magnet for cannatourists for years. Tourism with a cannabis twist is likely to gain steam in the coming years.

Technology

The numerous challenges that the marijuana industry faces have compelled players in this sector to look to technology for solutions. For example, the need to stand out from other competitors in the industry has led many businesses to leverage technology in order to come up with superior strains whose cannabinoid and terpene profile delivers an unmatched consumer experience.

Many companies have also come up with app-based solutions in order to reach their target customers and address the needs of those customers more effectively, especially companies that specialize in medical marijuana and want to track how the patients who use their products are progressing.

Many trends emerge and fade away fairly quickly, but these three trends appear poised to make their mark on the industry not just this year but for many more years to come as more states and countries cast their prohibitive laws aside.

These trends are likely to support industry growth at a high rate, and as the industry grows, so will the different companies such as American Cannabis Partners that are operating in the space.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Vantage Hemp Co. is in the Final Stages of its DMF Submissions

The usage of CBD as an active pharmaceutical ingredient is creating an overwhelming need for CBD manufacturers to identify their processes used in the manufacturing, packaging, and storing of pharmaceutical drug ingredients. On their way to set the industry bar, Colorado-based CBD manufacturer, Vantage Hemp Co., announces the company is in its final stages of its Drug Master File submissions to the US Food & Drug Administration. As one of the first CBD companies to file DMFs for all of its ingredients, Vantage is providing the FDA with confidential and detailed information about the quality and safety of its products. These submissions can be referenced by Vantage’s pharmaceutical partners when applying for FDA approval of their drug product.

To view the full press release, visit https://cnw.fm/fS9Hq

About Vantage Hemp Co.

With large-scale extraction facilities, Colorado-based Vantage Hemp Co. delivers pharmaceutical-grade GMP compliant CBD extracts (including full-spectrum oil, distillate and isolate) that companies can trust. Vantage’s contract manufacturing services offer a broad range of benefits as they operate with integrity and abide by stringent pharmaceutical-production standards to provide quality products to their partners.

Brooke Russell

Marigold Marketing & PR

1-877-681-5541

brussell@marigoldpr.com

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.